OEC Orion S.A.
Miscellaneous Chemical Products · NYSE · SEC CIK 1609804 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.9%
TTM net income YoY-1.6%
TTM EPS YoY0.0%
Revenue 3-yr CAGR-0.8%
Net income 3-yr CAGR—
Margins
Gross margin18.5%
Operating margin4.0%
Net margin-1.8%
FCF margin2.4%
EBITDA margin11.6%
Returns
ROE-8.1%
ROA-1.6%
ROIC (approx.)2.7%
Asset turnover0.94x
Leverage & solvency
Liabilities / assets79.7%
Debt / equity2.48x
Current ratio1.06x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-5.13x
Accruals ratio-10.1%
Payout ratio—
Capex / revenue6.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.81B | $1.88B | $1.89B | $2.03B | $1.55B |
| Cost of revenue | $1.45B | $1.45B | $1.44B | $1.58B | $1.16B |
| Gross profit | $359.80M | $428.80M | $451.00M | $448.80M | $386.60M |
| R&D expense | $27.50M | $27.10M | $24.50M | $21.70M | $22.00M |
| SG&A expense | $230.70M | $237.80M | $221.90M | $227.10M | $210.40M |
| Operating income | $27.50M | $102.70M | $205.30M | $197.10M | $228.50M |
| Interest expense | — | — | $50.90M | $39.90M | $38.00M |
| Pretax income | -$34.30M | $53.90M | $163.80M | $157.70M | $186.40M |
| Income tax | $35.80M | $9.70M | $60.30M | $51.50M | $51.70M |
| Net income | -$70.10M | $44.20M | $103.50M | $106.20M | $134.70M |
| EBITDA | $159.40M | $228.00M | $318.30M | $302.80M | $332.60M |
| EPS (basic) | -1.24 | 0.76 | 1.75 | 1.74 | 2.22 |
| EPS (diluted) | -1.24 | 0.76 | 1.73 | 1.73 | 2.21 |
| Dividends declared per share | 0.08 | 0.08 | 0.08 | 0.08 | 0.02 |
| Weighted avg. shares (diluted) | 56.32M | 58.37M | 59.98M | 61.38M | 60.95M |
| Balance sheet | |||||
| Cash & equivalents | $60.70M | $44.70M | $37.50M | $63.40M | $68.50M |
| Receivables | $213.60M | $211.90M | $241.00M | $367.80M | $288.90M |
| Inventory | $277.30M | $290.40M | $287.10M | $277.90M | $229.80M |
| Current assets | $643.80M | $613.30M | $646.10M | $778.50M | $665.00M |
| PP&E, net | $1.07B | $965.00M | $900.10M | $818.50M | $707.90M |
| Goodwill | $0 | $71.50M | $76.10M | $73.40M | $78.00M |
| Intangibles | $14.20M | $18.50M | $25.50M | $27.80M | $36.30M |
| Total assets | $1.91B | $1.86B | $1.83B | $1.89B | $1.63B |
| Current liabilities | $626.40M | $516.70M | $440.30M | $552.80M | $448.70M |
| Short-term debt | $305.00M | $258.80M | $137.00M | $258.30M | $151.70M |
| Long-term debt | $674.50M | $647.00M | $677.30M | $657.00M | $631.20M |
| Total debt | $979.50M | $905.80M | $814.30M | $915.30M | $782.90M |
| Total liabilities | $1.52B | $1.38B | $1.35B | $1.43B | $1.31B |
| Shareholders' equity | $384.60M | $474.90M | $478.50M | $459.40M | $319.70M |
| Net debt | $918.80M | $861.10M | $776.80M | $851.90M | $714.40M |
| Shares outstanding | 56.15M | 57.24M | 57.90M | 60.57M | 60.66M |
| Cash flow statement | |||||
| Operating cash flow | $215.80M | $125.30M | $345.90M | $81.00M | $145.20M |
| Capital expenditure | $161.00M | $206.70M | $172.80M | $232.80M | $214.70M |
| Free cash flow | $54.80M | -$81.40M | $173.10M | -$151.80M | -$69.50M |
| Investing cash flow | -$161.00M | -$206.70M | -$172.80M | -$232.80M | -$214.70M |
| Financing cash flow | -$41.20M | $89.30M | -$197.10M | $149.30M | $73.30M |
| Depreciation & amortization | $131.90M | $125.30M | $113.00M | $105.70M | $104.10M |
| Stock-based compensation | $13.60M | $15.30M | $15.40M | $7.70M | $5.20M |
| Dividends paid | $4.70M | $4.80M | $4.90M | $5.00M | $0 |
| Share buybacks | $24.80M | $26.60M | $65.60M | $4.30M | $0 |
Free plan shows the latest 5 periods; Pro shows all 11 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.